Presentation is loading. Please wait.

Presentation is loading. Please wait.

Supplemental Figure 1 Sham+Sham (N = 40) Sham+SPX (N = 40) AAC+Sham (N = 40) AAC+SPX (N = 40) AAC+SPX+IL-10 (N = 40) Day 2Day 4Day 14Day 28 echocardiography.

Published byCamilla Goodman Modified over 9 years ago

Similar presentations

Presentation on theme: "Supplemental Figure 1 Sham+Sham (N = 40) Sham+SPX (N = 40) AAC+Sham (N = 40) AAC+SPX (N = 40) AAC+SPX+IL-10 (N = 40) Day 2Day 4Day 14Day 28 echocardiography."— Presentation transcript:

1 Supplemental Figure 1 Sham+Sham (N = 40) Sham+SPX (N = 40) AAC+Sham (N = 40) AAC+SPX (N = 40) AAC+SPX+IL-10 (N = 40) Day 2Day 4Day 14Day 28 echocardiography 8 Flowcytometry, western blotting 8 cytokine’s assays, qPCR, Westernblotting using LA and spleen immunostaining of LA and spleen 8 cytokine’s assays, qPCR, westernblotting using LA and spleen immunostaining of LA and spleen 8 cytokine’s assays, qPCR, westernblotting using LA immunostaining of LA 8 cytokine’s assays, qPCR, westernblotting using LA immunostaining of LA 8 cytokine’s assays, qPCR, westernblotting using LA immunostaining of LA 8 immunostaining of LA and spleen 8 immunostaining of LA and spleen 8 immunostaining of LA 8 immunostaining of LA 8 immunostaining of LA 8 immunostaining of LA and spleen 8 immunostaining of LA and spleen 8 immunostaining of LA 8 immunostaining of LA 8 immunostaining of LA 8 EPS, special or immunostaining of LA, LV and spleen 8 EPS, special or immunostaining of LA, LV and spleen 8 EPS, special or immunostaining of LA, LV 8 EPS, special or immunostaining of LA, LV 8 EPS, special or immunostaining of LA, LV 8 Flowcytometry, western blotting

2 Supplemental Figure 2

3 Supplemental Figure 3

4 Supplemental Figure 4

5 Supplemental Figure 5

6 Supplemental Figure 6

7 Supplemental Figure 7 C

8 Supplemental Figure 8

9 Supplemental Figure 9

10 Supplemental Figure 10

Download ppt "Supplemental Figure 1 Sham+Sham (N = 40) Sham+SPX (N = 40) AAC+Sham (N = 40) AAC+SPX (N = 40) AAC+SPX+IL-10 (N = 40) Day 2Day 4Day 14Day 28 echocardiography."

Similar presentations

Regulation of DNA Methylation by Pro-Inflammatory Cytokines in Rheumatoid Arthritis Kazuhisa Nakano, David L. Boyle and Gary S. Firestein Division of Rheumatology,

Regulation of DNA Methylation by Pro-Inflammatory Cytokines in Rheumatoid Arthritis Kazuhisa Nakano, David L. Boyle and Gary S. Firestein Division of Rheumatology,
Supplemental Figure 1 A No. at risk T3 530 483 304 185 50 T2 559 545 373 228 76 T1 540 532 375 208 64.

Supplemental Figure 1 A No. at risk T T T
P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.
Immunology: diagnosing infections. What is diagnostic immunology? Term for a variety of diagnostic techniques that rely on the specificity of the bond.

Immunology: diagnosing infections. What is diagnostic immunology? Term for a variety of diagnostic techniques that rely on the specificity of the bond.
P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.
Type-1 NF1 constitutional microdeletions (1/2) MLPA qPCR Development of a probe-based qPCR assay for the detection of constitutional and somatic deletions.

Type-1 NF1 constitutional microdeletions (1/2) MLPA qPCR Development of a probe-based qPCR assay for the detection of constitutional and somatic deletions.
Supplementary data d a c d ab b Figure S1. Quantification of the Western blot data in figure 4C. The area density of each band was measured with a UVP.

Supplementary data d a c d ab b Figure S1. Quantification of the Western blot data in figure 4C. The area density of each band was measured with a UVP.
System Engineering M2D3 11.03.09. Three part lab today Part 1: finish Western Part 2:  -gal assay for your mutants Part 3: sequence analysis.

System Engineering M2D Three part lab today Part 1: finish Western Part 2:  -gal assay for your mutants Part 3: sequence analysis.
Supplemental Digital Content 1Supplemental Digital Content 2 Supplemental Digital Content 3Supplemental Digital Content 4.

Supplemental Digital Content 1Supplemental Digital Content 2 Supplemental Digital Content 3Supplemental Digital Content 4.
Supplementary Figure 1. Compararison of the expression of the genes within the 10q23 locus using either Troglitazone or Rosiglitazone as the PPAR  agonist.

Supplementary Figure 1. Compararison of the expression of the genes within the 10q23 locus using either Troglitazone or Rosiglitazone as the PPAR  agonist.
Supplemental Figure 1: ER  expression in MCF-7 cells. MCF-7 cells were either pre-treated with ICI 182,780 (lanes 5-8) or EtOH (vehicle, lanes 1-4) for.

Supplemental Figure 1: ER  expression in MCF-7 cells. MCF-7 cells were either pre-treated with ICI 182,780 (lanes 5-8) or EtOH (vehicle, lanes 1-4) for.
Principles of ER cotranslational translocation revealed by proximity-specific ribosome profiling Calvin H. Jan, Christopher C. Williams, Jonathan S. Weissman.

Principles of ER cotranslational translocation revealed by proximity-specific ribosome profiling Calvin H. Jan, Christopher C. Williams, Jonathan S. Weissman.
SNU423 SK-Hep1 HepG2 HA22T AR GAPDH Supplemental Fig. S1 Endogenous AR expression in various HCC cell lines Supplemental Fig. S2 Multiple E:T ratio for.

SNU423 SK-Hep1 HepG2 HA22T AR GAPDH Supplemental Fig. S1 Endogenous AR expression in various HCC cell lines Supplemental Fig. S2 Multiple E:T ratio for.
B A P-AXL P-AXL AXL AXL P-MET P-MET MET MET P-Akt-473 P-Akt-473 AKT

B A P-AXL P-AXL AXL AXL P-MET P-MET MET MET P-Akt-473 P-Akt-473 AKT
Figure 3. Elevation of p53 and its acetylation after treatment with FK866 and nicotinamide adenine dinucleotide (NAD+). Cells were treated for 72 hours.

Figure 3. Elevation of p53 and its acetylation after treatment with FK866 and nicotinamide adenine dinucleotide (NAD+). Cells were treated for 72 hours.
Fig. 1. TTE demonstrating a 2. 4×1

Fig. 1. TTE demonstrating a 2. 4×1
Finding the potential miRNA-binding sites of the selected SNPs

Finding the potential miRNA-binding sites of the selected SNPs
Invest. Ophthalmol. Vis. Sci ;52(8): doi: /iovs Figure Legend:

Invest. Ophthalmol. Vis. Sci ;52(8): doi: /iovs Figure Legend:
Volume 104, Issue 5, Pages (November 1993)

Volume 104, Issue 5, Pages (November 1993)
Four-chamber view of contrast echocardiography using agitated saline, showing microbubbles opacifying the left heart five beats after they were seen in.

Four-chamber view of contrast echocardiography using agitated saline, showing microbubbles opacifying the left heart five beats after they were seen in.

Similar presentations

Ads by Google